BRWM
JUNO

B. Riley Wealth Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

B. Riley Wealth Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,500
Closed -$90K – 1113
2015
Q1 		$90K Buy
+1,500
New +$72.8K 0.07% 305

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

B. Riley Wealth Management's JUNO Position: Q2 2015 in Review

B. Riley Wealth Management sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2015, closing a stake of 1,500 shares — an estimated $90K sold.

B. Riley Wealth Management first reported a position in JUNO in Q1 2015 and held it in 1 quarter. The position peaked at $90K in Q1 2015. 154 funds tracked by Wall St. Rank hold JUNO as of Q2 2015.

  • B. Riley Wealth Management reported no remaining Juno Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 1,500 Juno Therapeutics, Inc. shares in Q2 2015, an estimated $90K.
  • B. Riley Wealth Management first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 1 quarter.
  • B. Riley Wealth Management's Juno Therapeutics, Inc. position peaked at $90K in Q1 2015.
  • 154 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2015.

Based on B. Riley Wealth Management's 13F filing for Q2 2015, filed 14 Jul 2015.